4-substituted quinolein derivatives with antimicrobial activity

Details for Australian Patent Application No. 2004226207 (hide)

Owner Aventis Pharma S.A.

Inventors Pantel, Guy; Bigot, Antony; Tabart, Michel; Martin, Jean-Paul; Cheve, Michel; Malleron, Jean-Luc; Mignani, Serge; Ronan, Baptiste; Viviani, Fabrice; El Ahmad, Youssef

Agent Spruson & Ferguson

Pub. Number AU-A-2004226207

PCT Pub. Number WO2004/087647

Priority 03/03812 28.03.03 FR

Filing date 29 March 2004

Wipo publication date 14 October 2004

International Classifications

C07D 409/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 401/06 Heterocyclic compounds containing two or more hetero rings

Event Publications

10 November 2005 PCT application entered the National Phase

  PCT publication WO2004/087647 Priority application(s): WO2004/087647

3 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004226212-A process for the preparation of 5-(haloacetyl)-8-(substituted oxy)-(1H)-quinolin-2-ones

2004226205-Method and device for bending glass sheets